GALT vs AMGN: Which Stock is Better?

Side-by-side comparison of Galectin Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

GALT

Galectin Therapeutics Inc

$2.26

AMGN

Amgen Inc

$349.39

Key Metrics Comparison

MetricGALTAMGNWinner
Market Cap$168.52M$187.71BAMGN
P/E RatioN/A24.45AMGN
EPS (TTM)$N/A$14.24AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.8%AMGN

Analyze GALT

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is GALT or AMGN a better investment?

Comparing GALT and AMGN: Galectin Therapeutics Inc has a market cap of $168.52M while Amgen Inc has $187.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between GALT and AMGN?

GALT (Galectin Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: GALT or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: GALT or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for GALT.

Which company is more profitable: GALT or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for GALT.

Which is the larger company: GALT or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $187.71B compared to $168.52M for GALT.

Should I buy GALT or AMGN in 2026?

Both GALT and AMGN have investment merit. GALT trades at $2.26 while AMGN trades at $349.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between GALT and AMGN stock?

Key differences: Market Cap ($168.52M vs $187.71B), P/E Ratio (N/A vs 24.5x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).

Popular Stock Comparisons